Skip Navigation

Cardiovascular Research 2005 67(2):283-290; doi:10.1016/j.cardiores.2005.03.018
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Backs, J.
Right arrow Articles by Haass, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Backs, J.
Right arrow Articles by Haass, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2005, European Society of Cardiology

Endothelin-1 inhibits the neuronal norepinephrine transporter in hearts of male rats

Johannes Backs*,1, Elke Bresch2, Matthias Lutz, Arnt V. Kristen and Markus Haass3

Department of Cardiology, University of Heidelberg, INF 410, D-69120 Heidelberg, Germany

* Corresponding author. Tel.: +49 6221 568611; fax: +49 6221 565515. Email address: johannes.backs{at}web.de

Objective: Endothelin-1 (ET-1) potentiates norepinephrine (NE)-induced contractile responses. An impairment of cardiac NE re-uptake by the neuronal NE transporter (NET) contributes to an increased NE net release in failing hearts. We hypothesized that both phenomena are caused by ET-1-mediated inhibition of NET.

Methods: [3H]-NE-uptake, electrical field stimulation-evoked NE overflow and left ventricular contractility (LV-dp/dtmax) were measured in isolated perfused rat hearts. NET density on cardiac plasma membranes was determined by [3H]-mazindol binding. Experimental heart failure in rats was induced by transverse aortic constriction (TAC).

Results: ET-1 inhibited cardiac [3H]-NE-uptake in a concentration- and time-dependent manner. The endothelin A receptor (ETA) antagonist BQ123 but not the endothelin B receptor (ETB) antagonist BQ788 abolished ET-1-induced reduction of [3H]-NE-uptake. Likewise, ET-1, but not the ETB agonist sarafotoxin S6c, enhanced the stimulated overflow of endogenous NE. In contrast, ET-1 inhibited the stimulated NE overflow during NET blockade (exocytotic NE release) via activation of ETB. In isovolumically contracting healthy hearts, ET-1 potentiated the NE- but not isoprenaline-induced increase in LV-dp/dtmax. Since isoprenaline is not a NET substrate, the enhanced LV-dp/dtmax response to NE thus depends on NET. In TAC rats, ETA antagonism by darusentan improved both impairment of cardiac [3H]-NE-uptake and reduction of [3H]-mazindol binding sites.

Conclusion: ET-1 inhibits cardiac NE re-uptake via ETA but attenuates exocytotic NE release via ETB, resulting in opposite effects on cardiac NE net release. In healthy hearts, ETA-mediated inhibition of NE re-uptake exceeds ETB-mediated silencing of NE release and potentiates the NE-induced increase in left ventricular contractility. In TAC rats, endogenous ET-1 impairs NE re-uptake and promotes sympathetic overstimulation of failing hearts.

KEYWORDS Autonomic nervous system; Norepinephrine; Norepinephrine transporter; Endothelins; Heart failure

1 Current address: UT Southwestern, 5323 Harry Hines Blvd., Dallas, TX 75390-9148, USA.

2 Current address: Cardiology and Pneumology, Free University of Berlin, HBD 30, 12200 Berlin, Germany.

3 Current address: Cardiology, Theresienkrankenhaus, Bassermannstrasse 1, 68165 Mannheim, Germany.

Time for primary review 18 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Exp. Biol. Med.Home page
V. A. Rufanova, V. F. Pozdnev, E. I. Kalenikova, A. B. Postnikov, A. N. Storozhilova, V. P. Masenko, O. A. Gomazkov, O. S. Medvedev, and N. A. Medvedeva
Endothelin-Converting Enzyme Inhibition in the Rat Model of Acute Heart Failure: Heart Function and Neurohormonal Activation
Experimental Biology and Medicine, October 1, 2009; 234(10): 1201 - 1211.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
K. Kimura, M. Ieda, H. Kanazawa, T. Yagi, M. Tsunoda, S.-i. Ninomiya, H. Kurosawa, K. Yoshimi, H. Mochizuki, K. Yamazaki, et al.
Cardiac Sympathetic Rejuvenation: A Link Between Nerve Function and Cardiac Hypertrophy
Circ. Res., June 22, 2007; 100(12): 1755 - 1764.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. J. Buss, J. Backs, M. M. Kreusser, S. E. Hardt, C. Maser-Gluth, H. A. Katus, and M. Haass
Spironolactone Preserves Cardiac Norepinephrine Reuptake in Salt-Sensitive Dahl Rats
Endocrinology, May 1, 2006; 147(5): 2526 - 2534.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. M. Kreusser, M. Haass, S. J. Buss, S. E. Hardt, S. H. Gerber, R. Kinscherf, H. A. Katus, and J. Backs
Injection of Nerve Growth Factor Into Stellate Ganglia Improves Norepinephrine Reuptake Into Failing Hearts
Hypertension, February 1, 2006; 47(2): 209 - 215.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.